UC Board of Regents Gives Approval for New Clinical and Translational Research Institute Building on UC San Diego’s La Jolla Campus

 

November 18, 2010  |  

The University of California Board of Regents on Tuesday approved the budget for capital improvements and external financing for the Clinical and Translational Research Institute (CTRI) building, to be constructed on the medical campus of UC San Diego in La Jolla.  The CTRI building will be in close proximity to Thornton Hospital, Moores Cancer Center, the soon-to-open Sulpizio Cardiovascular Center and the recently announced Jacobs Medical Center.

“The CTRI building will create a unique multidisciplinary environment that brings together laboratory scientists and clinical investigators to understand disease, develop new methods of treatment and translate clinical research results into clinical practice,” said Gary S. Firestein, MD, professor of medicine, dean and associate vice chancellor of Translational Medicine and director of the Clinical and Translational Research Institute at UCSD School of Medicine.

The new building, currently slated for completion in late 2016, will comprise 311,000 gsf and 189,000 asf (assignable square feet) including  wet and dry research space, and clinical research space to support investigators in the School of Medicine.

The projected cost of the project is $269 million, which will be primarily paid for with external funding sources rather than state dollars, according to UC San Diego administrators.

# # #

Media Contact: Debra Kain, 619-543-6163, ddkain@ucsd.edu




Media Contact

Share This Article


Related News

10/18/2017
Modeling the interplay between neurons and astrocytes derived from children with Autism Spectrum Disorder (ASD), researchers at University of California San Diego School of Medicine, with colleagues i ...
10/10/2017
Despite a diagnosis of stage IV pancreatic cancer and ongoing chemotherapy, Mike Levine boarded a plane this past weekend destined for Kona, Hawaii, where he will compete in one of the most grueling o ...
10/10/2017
Approximately 10 percent of Americans take a proton pump inhibitor drug to relieve symptoms of frequent heartburn and acid reflux. That percentage can be much higher for people with chronic liver dise ...
10/9/2017
Researchers at University of California San Diego School of Medicine, with national collaborators, have identified a series of molecular clues to understanding the formation of cerebral cavernous malf ...



Follow Us